Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    September 2018
  1. SENFT D, Jeremias I
    A rare subgroup of leukemia stem cells harbours relapse-inducing potential in acute lymphoblastic leukemia.
    Exp Hematol. 2018 Sep 24. pii: S0301-472X(18)30807.
    PubMed     Text format     Abstract available


  2. LI X, Xu L, Shen X, Cai J, et al
    Up-regulated miR-146a expression induced by G-CSF enhanced low dosage chemotherapy response in aged acute myeloid leukemia patients.
    Exp Hematol. 2018 Sep 9. pii: S0301-472X(18)30799.
    PubMed     Text format     Abstract available


  3. PAN B, Yang J, Wang X, Xu K, et al
    miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
    Exp Hematol. 2018 Sep 5. pii: S0301-472X(18)30798.
    PubMed     Text format     Abstract available


  4. HEIBLIG M, Rea D, Chretien ML, Charbonnier A, et al
    Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: The PEARL observational study.
    Exp Hematol. 2018 Sep 5. pii: S0301-472X(18)30795.
    PubMed     Text format     Abstract available


    August 2018
  5. GAO S, Zhou B, Li H, Huang X, et al
    Long non-coding RNA HOTAIR promotes the self-renewal of leukemia stem cell through epigenetic silencing of p15.
    Exp Hematol. 2018 Aug 30. pii: S0301-472X(18)30752.
    PubMed     Text format     Abstract available


  6. BORGES CS, Ferreira AF, Almeida VH, Gomes FG, et al
    CROSSTALK BETWEEN BCR-ABL AND PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) SUGGESTS A NOVEL TARGET IN CHRONIC MYELOID LEUKEMIA.
    Exp Hematol. 2018 Aug 1. pii: S0301-472X(18)30746.
    PubMed     Text format     Abstract available


    July 2018
  7. KOTB A, Fakih RE, Hanbali A, Hawsawi Y, et al
    Philadelphia-Like Acute Lymphoblastic Leukemia: Diagnostic dilemma and management perspectives.
    Exp Hematol. 2018 Jul 31. pii: S0301-472X(18)30743.
    PubMed     Text format     Abstract available


    May 2018
  8. NICOLINI FE, Alcazer V, Cony-Makhoul P, Heiblig M, et al
    Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line.
    Exp Hematol. 2018 May 22. pii: S0301-472X(18)30259.
    PubMed     Text format     Abstract available


  9. SHI X, Kitano A, Jiang Y, Luu V, et al
    Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.
    Exp Hematol. 2018 May 8. pii: S0301-472X(18)30256.
    PubMed     Text format     Abstract available


  10. JENKINS CE, Gusscott S, Wong RJ, Shevchuk OO, et al
    RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30217.
    PubMed     Text format     Abstract available


  11. DESTERKE C, Voldoire M, Bonnet ML, Sorel N, et al
    Experimental and integrative analyses identify an ETS1 network downstream BCR-ABL in chronic myeloid leukemia (CML).
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30216.
    PubMed     Text format     Abstract available


    April 2018
  12. THURGOOD LA, Lower KM, Macardle C, Kuss BJ, et al
    Aberrant detection of phenotypic markers in chronic lymphocytic leukemia (CLL) lymphocytes following cryopreservation.
    Exp Hematol. 2018 Apr 26. pii: S0301-472X(18)30172.
    PubMed     Text format     Abstract available


    March 2018
  13. NEWCOMBE AA, Gibson BES, Keeshan K
    Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Exp Hematol. 2018 Mar 30. pii: S0301-472X(18)30166.
    PubMed     Text format     Abstract available


  14. ORTI G, Sanz J, Garcia-Cadenas I, Sanchez-Ortega I, et al
    Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions.
    Exp Hematol. 2018 Mar 8. pii: S0301-472X(18)30120.
    PubMed     Text format     Abstract available


    February 2018
  15. ZYLBERSZTEJN F, Flores-Violante M, Voeltzel T, Nicolini FE, et al
    The BMP pathway: a unique tool to decode origin and progression of leukemia.
    Exp Hematol. 2018 Feb 22. pii: S0301-472X(18)30077.
    PubMed     Text format     Abstract available


  16. LI H, Xing C, Zhou B, Ye H, et al
    A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
    Exp Hematol. 2018 Feb 13. pii: S0301-472X(18)30041.
    PubMed     Text format     Abstract available


  17. DUSSIAU C, Fontenay M
    Mechanisms underlying the heterogeneity of myelodysplastic syndromes.
    Exp Hematol. 2018;58:17-26.
    PubMed     Text format     Abstract available


    January 2018
  18. GONG Y, Zhao M, Yang W, Gao A, et al
    Megakaryocyte-derived excessive TGFbeta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.
    Exp Hematol. 2018 Jan 4. pii: S0301-472X(17)30909.
    PubMed     Text format     Abstract available


    December 2017
  19. GRIESSINGER E, Vargaftig J, Horswell S, Taussig DC, et al
    Acute myeloid leukemia xenograft success prediction: saving time.
    Exp Hematol. 2017 Dec 15. pii: S0301-472X(17)30900.
    PubMed     Text format     Abstract available


    November 2017
  20. CASTAGNA L, Devillier R, Vey N, Blaise D, et al
    T cell replete-haploidentical transplantation in acute myeloid leukemia.
    Exp Hematol. 2017 Nov 16. pii: S0301-472X(17)30861.
    PubMed     Text format     Abstract available


  21. CULL AH, Snetsinger B, Buckstein R, Wells RA, et al
    Tet2 restrains inflammatory gene expression in macrophages.
    Exp Hematol. 2017;55:56-70.
    PubMed     Text format     Abstract available


    October 2017
  22. BOILA LD, Chatterjee SS, Banerjee D, Sengupta A, et al
    KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.
    Exp Hematol. 2017 Oct 27. pii: S0301-472X(17)30824.
    PubMed     Text format     Abstract available


  23. WILLMANN M, Sadovnik I, Eisenwort G, Entner M, et al
    Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.
    Exp Hematol. 2017 Oct 12. pii: S0301-472X(17)30816.
    PubMed     Text format     Abstract available


  24. HASSAN C, Afshinnekoo E, Li S, Wu S, et al
    Genetic and epigenetic heterogeneity and the impact on cancer relapse.
    Exp Hematol. 2017;54:26-30.
    PubMed     Text format     Abstract available


    September 2017
  25. GREGORY MA, Nemkov T, Reisz JA, Zaberezhnyy V, et al
    Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Exp Hematol. 2017 Sep 22. pii: S0301-472X(17)30776.
    PubMed     Text format     Abstract available


  26. LAGACE K, Barabe F, Hebert J, Cellot S, et al
    Identification of novel biomarkers for MLL translocated acute myeloid leukemia.
    Exp Hematol. 2017 Sep 11. pii: S0301-472X(17)30758.
    PubMed     Text format     Abstract available


  27. CHAN LN, Muschen M
    B-cell identity as a metabolic barrier against malignant transformation.
    Exp Hematol. 2017;53:1-6.
    PubMed     Text format     Abstract available


    August 2017
  28. HEROLD N, Rudd SG, Sanjiv K, Kutzner J, et al
    With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
    Exp Hematol. 2017;52:32-39.
    PubMed     Text format     Abstract available


  29. KIM YM, Gang EJ, Kahn M
    CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
    Exp Hematol. 2017;52:1-11.
    PubMed     Text format     Abstract available


    July 2017
  30. ZHANG J, Griffith M, Miller CA, Griffith OL, et al
    Comprehensive discovery of non-coding RNAs in acute myeloid leukemia cell transcriptomes.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30701.
    PubMed     Text format     Abstract available


  31. YALCIN A, Kovarbasic M, Wehrle J, Claus R, et al
    The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30702.
    PubMed     Text format     Abstract available


  32. MARTINO B, Mammi C, Labate C, Rodi S, et al
    Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30663.
    PubMed     Text format     Abstract available


  33. CARRETTA M, de Boer B, Jaques J, Antonelli A, et al
    Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Exp Hematol. 2017;51:36-46.
    PubMed     Text format     Abstract available


  34. LEPRETRE S, Graux C, Touzart A, Macintyre E, et al
    Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators.
    Exp Hematol. 2017;51:7-16.
    PubMed     Text format     Abstract available


    June 2017
  35. LAING AA, Harrison CJ, Gibson BES, Keeshan K, et al
    Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Exp Hematol. 2017 Jun 28. pii: S0301-472X(17)30237.
    PubMed     Text format     Abstract available


  36. SANDA T, Leong WZ
    TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 Jun 23. pii: S0301-472X(17)30231.
    PubMed     Text format     Abstract available


  37. SLOMA I, Mitjavila-Garcia M, Feraud O, Griscelli F, et al
    Whole genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.
    Exp Hematol. 2017 Jun 7. pii: S0301-472X(17)30192.
    PubMed     Text format     Abstract available


  38. PORTER SN, Magee JA
    PRKCH regulates hematopoietic stem cell function and predicts poor prognosis in acute myeloid leukemia.
    Exp Hematol. 2017 Jun 5. pii: S0301-472X(17)30190.
    PubMed     Text format     Abstract available


    May 2017
  39. OMORI I, Yamaguchi H, Miyake K, Miyake N, et al
    D816V mutation in the KIT gene activation loop has a greater cell proliferative and anti-apoptotic ability than N822K mutation in core binding factor-acute myeloid leukemia.
    Exp Hematol. 2017 May 12. pii: S0301-472X(17)30146.
    PubMed     Text format     Abstract available


  40. SHEN Y, Chen TJ, Lacorazza HD
    Novel tumor suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 May 4. pii: S0301-472X(17)30141.
    PubMed     Text format     Abstract available


    April 2017
  41. SADOVNIK I, Herrmann H, Eisenwort G, Blatt K, et al
    Expression of CD25 on Leukemic Stem Cells in BCR-ABL1+ CML: Potential Diagnostic Value and Functional Implications.
    Exp Hematol. 2017 Apr 27. pii: S0301-472X(17)30135.
    PubMed     Text format     Abstract available


  42. VAN GILS N, Verhagen HJMP, Smit L
    Reprogramming acute myeloid leukemia into sensitivity for retinoic acid-driven differentiation.
    Exp Hematol. 2017 Apr 26. pii: S0301-472X(17)30139.
    PubMed     Text format     Abstract available


  43. SASAKI T, Rivera-Mulia JC, Vera D, Zimmerman J, et al
    Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Exp Hematol. 2017 Apr 19. pii: S0301-472X(17)30136.
    PubMed     Text format     Abstract available


  44. CHOI EJ, Kim MS, Yoo NJ, Lee SH, et al
    Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas.
    Exp Hematol. 2017;48:39-40.
    PubMed     Text format    


    March 2017
  45. GHOSH J, Kapur R
    Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Exp Hematol. 2017 Mar 22. pii: S0301-472X(17)30063.
    PubMed     Text format     Abstract available


  46. CLARKE CJ, Holyoake TL
    Preclinical approaches in chronic myeloid leukemia: from cells to systems.
    Exp Hematol. 2017;47:13-23.
    PubMed     Text format     Abstract available


  47. UTTARKAR S, Frampton J, Klempnauer KH
    Targeting the transcription factor Myb by small-molecule inhibitors.
    Exp Hematol. 2017;47:31-35.
    PubMed     Text format     Abstract available


  48. BOGEN A, Buske C, Hiddemann W, Bohlander SK, et al
    Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
    Exp Hematol. 2017;47:54-63.
    PubMed     Text format     Abstract available


    February 2017
  49. YOKOYAMA A
    Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Exp Hematol. 2017;46:21-30.
    PubMed     Text format     Abstract available


    January 2017
  50. AN X, Liu J, Wang N, Wang D, et al
    AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes.
    Exp Hematol. 2017;45:36-44.
    PubMed     Text format     Abstract available


    May 2016
  51. TESTA U, Labbaye C, Castelli G, Pelosi E, et al
    Oxidative Stress and Hypoxia in Normal and Leukemic Stem Cells.
    Exp Hematol. 2016 May 11. pii: S0301-472X(16)30116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: